(Q36420168)

English

High-dose carboplatin, etoposide and melphalan (CEM) with peripheral blood progenitor cell support as late intensification for high-risk cancer: non-haematological, haematological toxicities and role of growth factor administration

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

High-dose carboplatin, etoposide and melphalan (CEM) with peripheral blood progenitor cell support as late intensification for high-risk cancer: non-haematological, haematological toxicities and role of growth factor administration (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1 reference

based on heuristic

1 reference

based on heuristic

author name string

Benedetti Panici P

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Pierelli L

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Scambia G

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Foddai ML

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Salerno MG

5

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Menichella G

6

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Vittori M

7

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Maneschi F

8

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Caracussi U

9

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Serafini R

10

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Leone G

11

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Mancuso S

12

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

language of work or name

0 references

publication date

1 January 1997

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

75

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

8

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1205-1212

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

https://scigraph.springernature.com/pub.10.1038/bjc.1997.206

0 references

High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

30 September 2017

Intensive chemotherapy with autologous bone marrow transfusion as primary treatment in women with breast cancer and more than five involved axillary lymph nodes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

30 September 2017

High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

30 September 2017

High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

30 September 2017

Effect of granulocyte colony-stimulating factor on hematopoietic recovery after peripheral blood progenitor cell transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

30 September 2017

Autologous transplantation of peripheral blood progenitor cells mobilized by chemotherapy with or without G-CSF (filgrastim) in resistant lymphoproliferative diseases: enhanced hemopoietic recovery with filgrastim primed progenitors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

30 September 2017

Randomized study of growth factors post-peripheral-blood stem-cell transplant: neutrophil recovery is improved with modest clinical benefit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

30 September 2017

Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

30 September 2017

Ovarian carcinoma. A decade of progress

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

30 September 2017

VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

30 September 2017

A pilot study of high-dose carboplatin and pulsed etoposide in the treatment of childhood solid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

30 September 2017

Autologous bone marrow transplantation for non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

30 September 2017

Etoposide. Current and future status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

30 September 2017

A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

30 September 2017

Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

30 September 2017

High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

28 June 2018

High dose cisplatin and high dose carboplatin in refractory ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

28 June 2018

High-dose combination alkylating agent therapy with autologous bone marrow rescue for refractory solid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

28 June 2018

A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

28 June 2018

Combination of the minor groove-binder U73-975 or the intercalator mitoxantrone with antitumor alkylating agents in MCF-7 or MCF-7/CP cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

28 June 2018

Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

28 June 2018

High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

28 June 2018

Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

28 June 2018

High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

21 September 2018

Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222783

21 September 2018

Autologous blood stem cell harvesting and transplantation in patients with advanced ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9099971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9099971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9099971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9099971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/9099971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide

1 reference

https://pubmed.ncbi.nlm.nih.gov/9099971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9099971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9099971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Haemopoietic reconstitution after autologous blood stem cell transplantation in patients with malignancies: a multicentre retrospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9099971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of a Novel Automated Protocol for the Collection of Peripheral Blood Stem Cells Mobilized with Chemotherapy or Chemotherapy Plus G-CSF Using the Fresenius AS104 Cell Separator

1 reference

https://pubmed.ncbi.nlm.nih.gov/9099971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/9099971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose ifosfamide/carboplatin/etoposide: maximum tolerable doses, toxicities, and hematopoietic recovery after autologous stem cell reinfusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/9099971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose cyclophosphamide in combination with cisplatin or epirubicin plus rhG-CSF allows adequate collection of PBSC for autotransplantation during adjuvant therapy for high-risk cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9099971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support

1 reference

https://pubmed.ncbi.nlm.nih.gov/9099971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I-II trial of high-dose cyclophosphamide, carboplatin and autologous bone marrow or peripheral blood stem cell rescue

1 reference

https://pubmed.ncbi.nlm.nih.gov/9099971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Very high-dose chemotherapy with autologous peripheral stem cell support in advanced ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9099971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I-II study of bialkylator chemotherapy, high-dose thiotepa, and cyclophosphamide with autologous bone marrow reinfusion in patients with advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9099971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late intensification with high-dose melphalan and autologous bone marrow support in breast cancer patients responding to conventional chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9099971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/9099971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/9099971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1997.206

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

release_izzjtkqf2rhnllqb5rrbq4swyi

1 reference

https://api.fatcat.wiki/v0/release/izzjtkqf2rhnllqb5rrbq4swyi

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36420168&oldid=1959522353"